PH12018501985A1 - Dutasteride-and tamsulosin-containing hard capsule complex and preparation method therefor - Google Patents
Dutasteride-and tamsulosin-containing hard capsule complex and preparation method thereforInfo
- Publication number
- PH12018501985A1 PH12018501985A1 PH12018501985A PH12018501985A PH12018501985A1 PH 12018501985 A1 PH12018501985 A1 PH 12018501985A1 PH 12018501985 A PH12018501985 A PH 12018501985A PH 12018501985 A PH12018501985 A PH 12018501985A PH 12018501985 A1 PH12018501985 A1 PH 12018501985A1
- Authority
- PH
- Philippines
- Prior art keywords
- dutasteride
- tamsulosin
- independent part
- hard capsule
- preparation
- Prior art date
Links
- DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 title abstract 5
- 229960002613 tamsulosin Drugs 0.000 title abstract 5
- 238000002360 preparation method Methods 0.000 title abstract 4
- 239000007902 hard capsule Substances 0.000 title abstract 3
- 238000010668 complexation reaction Methods 0.000 title 1
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 abstract 5
- 229960004199 dutasteride Drugs 0.000 abstract 5
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160031468 | 2016-03-16 | ||
| PCT/KR2017/002862 WO2017160106A2 (fr) | 2016-03-16 | 2017-03-16 | Complexe en capsule dure contenant du dutastéride et de la tamsulosine et son procédé de préparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12018501985A1 true PH12018501985A1 (en) | 2019-07-08 |
Family
ID=59850978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12018501985A PH12018501985A1 (en) | 2016-03-16 | 2018-09-14 | Dutasteride-and tamsulosin-containing hard capsule complex and preparation method therefor |
Country Status (8)
| Country | Link |
|---|---|
| KR (1) | KR101968754B1 (fr) |
| CN (1) | CN109152743B (fr) |
| AU (1) | AU2017233134A1 (fr) |
| BR (1) | BR112018068686A2 (fr) |
| EA (1) | EA201891843A1 (fr) |
| MX (1) | MX2018011208A (fr) |
| PH (1) | PH12018501985A1 (fr) |
| WO (1) | WO2017160106A2 (fr) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW369521B (en) | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| SI1618873T1 (sl) * | 2004-07-14 | 2007-10-31 | Siegfried Generics Int Ag | Granulat za kontrolirano sproščanje tamsulozina, ki vsebuje alginat |
| WO2006055659A2 (fr) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Composition pharmaceutique |
| CN102247379A (zh) * | 2011-01-12 | 2011-11-23 | 北京润德康医药技术有限公司 | 一种复方制剂及其制备方法 |
| CN102145007B (zh) * | 2011-03-03 | 2013-03-20 | 王致中 | 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法 |
| WO2014002015A1 (fr) * | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Composition pharmaceutique comprenant du dutastéride |
| BR112015021769A2 (pt) * | 2013-03-19 | 2017-07-18 | Galenicum Health Sl | composições farmacêuticas compreendendo um agente ativo |
| KR20160021095A (ko) * | 2013-06-21 | 2016-02-24 | 욱크하르트 리미티드 | 탐술로신 또는 이의 염의 약학 조성물 |
| EP2949319A1 (fr) * | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Compositions pharmaceutiques comprenant un agent actif |
| KR101590072B1 (ko) * | 2014-12-23 | 2016-01-29 | 한미약품 주식회사 | 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물 |
-
2017
- 2017-03-16 WO PCT/KR2017/002862 patent/WO2017160106A2/fr not_active Ceased
- 2017-03-16 AU AU2017233134A patent/AU2017233134A1/en not_active Abandoned
- 2017-03-16 KR KR1020170033369A patent/KR101968754B1/ko active Active
- 2017-03-16 MX MX2018011208A patent/MX2018011208A/es unknown
- 2017-03-16 EA EA201891843A patent/EA201891843A1/ru unknown
- 2017-03-16 CN CN201780029107.0A patent/CN109152743B/zh active Active
- 2017-03-16 BR BR112018068686A patent/BR112018068686A2/pt not_active Application Discontinuation
-
2018
- 2018-09-14 PH PH12018501985A patent/PH12018501985A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017160106A3 (fr) | 2018-09-07 |
| WO2017160106A2 (fr) | 2017-09-21 |
| KR20170107933A (ko) | 2017-09-26 |
| EA201891843A1 (ru) | 2019-04-30 |
| CN109152743B (zh) | 2022-01-07 |
| CN109152743A (zh) | 2019-01-04 |
| KR101968754B1 (ko) | 2019-04-12 |
| MX2018011208A (es) | 2019-05-30 |
| AU2017233134A1 (en) | 2018-10-04 |
| BR112018068686A2 (pt) | 2019-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289179A (en) | Spherical tantalum-titanium alloy powder, products containing the same, and methods of making the same | |
| MX384828B (es) | Formas solidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi]fenil}-n'-(4-fluorofenil)ciclopropan-1,1-dicarboxamida, procesos para elaboracion y metodos de uso. | |
| AR102767A1 (es) | Inhibidores de ezh2 | |
| PH12014500711A1 (en) | Seamless capsule and method of its production | |
| TW201613632A (en) | Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction | |
| NZ730882A (en) | Abuse resistant pharmaceutical compositions | |
| EA201992020A1 (ru) | Фармацевтический комбинированный состав капсулы, содержащий тадалафил и тамсулозин | |
| MX2025000572A (es) | Formulaciones de capsula de cubierta blanda y metodos de preparacion y uso de las mismas | |
| TN2014000152A1 (en) | Sustained-release preparation | |
| PH12019500919A1 (en) | Esomeprazole~containing complex capsule and preparation method therefor | |
| EA202090913A1 (ru) | Композиция таблеток с модифицированным высвобождением, содержащая мирабегрон | |
| EA201590474A1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ КОМПОЗИТНЫХ КАПСУЛ, ВКЛЮЧАЮЩИХ ИРБЕСАРТАН И ИНГИБИТОР ГМГ-КоА РЕДУКТАЗЫ | |
| PH12018501985A1 (en) | Dutasteride-and tamsulosin-containing hard capsule complex and preparation method therefor | |
| PH12019501327A1 (en) | Umami taste enhancing agent | |
| PH12017501314A1 (en) | Composite capsules comprising raloxifene, and vitamin d or its derivatives | |
| MX2019006939A (es) | Preparacion liquida parenteral que comprende compuesto de carbamato. | |
| TW201613581A (en) | Pharmaceutical composition for suppression of thromboembolization after stent placement | |
| EP3491937A4 (fr) | Agent d'assaisonnement liquide contenant des ingrédients solides | |
| TR201722186A2 (tr) | Dabi̇gatranin farmasöti̇k kompozi̇syonlari | |
| MX388082B (es) | Composicion farmaceutica de esomeprazol con bicarbonato de sodio en el proceso de preparacion de una capsula, para el tratamiento de alopatias relacionadas con la acidez gastrica. | |
| PL439306A1 (pl) | Liposomowy preparat cynku i miedzi oraz sposób jego wytwarzania | |
| Suseno et al. | Purification of Sardine Oil Using Adsorbent (Active Filter) of Scallop Shells, Carp Scales and Attapulgite | |
| SA519401554B1 (ar) | تركيبة قرص من الليناليدوميد يؤخذ عن طريق الفم | |
| MX390164B (es) | Composición farmacéutica de loratadina-fenilefrina para integrar una capsula, para el tratamiento de resfriados entre otras alopatías. | |
| TN2019000197A1 (fr) | Liquid filled hard capsule comprising effective and flexible single dose of vitamin D |